Abstract
Background/Objective:
Previous research has focused on associations between dietary fat and body mass index (BMI), but the contributions of different types of fat to BMI remain unclear. The purpose of this study is to estimate whether plasma phospholipid omega-3 (n−3), omega-6 (n−6) or trans fatty acids are associated with BMI at baseline and with subsequent BMI changes over time; and whether total phospholipid n−6 or trans fatty acids modify any association between phospholipid n−3 and BMI.
Methods:
Cross-sectional and longitudinal linear mixed models include 6243 participants in the Multi-Ethnic Study of Atherosclerosis (MESA) cohort. Participants were 45−84 years old, had no history of cardiovascular disease at baseline (2000−2002) and were followed for up to 10 years. Plasma phospholipid fatty acids were measured using fasting plasma samples at baseline. Fully adjusted models include demographics, health behaviors and other fatty acids (n−3, n−6 and trans) as appropriate.
Results:
In fully adjusted models, phospholipid n−3 fatty acid levels were inversely associated with baseline BMI (Ptrend <0.001). Baseline BMI was 1.14 (95% confidence interval (CI): 0.71, 1.57) kg m–2 lower among participants with total n−3 values in the highest vs the lowest quartiles, but was not associated with changes in BMI. Total phospholipid n−6 was positively associated with baseline BMI in partially adjusted but not fully adjusted models. No overall association was observed between fatty acid levels and changes in BMI. No clear association was observed between trans fatty acids and baseline BMI or BMI change. No effect modification in the association between phospholipid n−3 and baseline BMI or BMI change was observed by either phospholipid n−6 or trans fatty acids.
Conclusions:
Phospholipid total and specific n−3 fatty acid levels were inversely associated with BMI at baseline, whereas associations tended to be positive for total n−6 fatty acids. Significant associations between fatty acid levels and BMI changes were not observed.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout


References
Willett WC . Dietary fat plays a major role in obesity: no. Obes Rev 2002; 3: 59–68.
Field AE, Willett WC, Lissner L, Colditz GA . Dietary fat and weight gain among women in the Nurses’ Health Study. Obesity 2007; 15: 967–976.
Balk EM, Lichtenstein AH, Chung M, Kupelnick B, Chew P, Lau J . Effects of omega-3 fatty acids on serum markers of cardiovascular disease risk: a systematic review. Atherosclerosis 2006; 189: 19–30.
Harris WS, Mozaffarian D, Rimm E, Kris-Etherton P, Rudel LL, Appel LJ et al. Omega-6 fatty acids and risk for cardiovascular disease a science advisory from the American Heart Association Nutrition Subcommittee of the Council on Nutrition, Physical Activity, and Metabolism; Council on Cardiovascular Nursing; and Council on Epidemiology and Prevention. Circulation 2009; 119: 902–907.
Couet C, Delarue J, Ritz P, Antoine J-M, Lamisse F . Effect of dietary fish oil on body fat mass and basal fat oxidation in healthy adults. Int J Obes 1997; 21: 637–643.
Ailhaud G, Guesnet P . Fatty acid composition of fats is an early determinant of childhood obesity: a short review and an opinion. Obes Rev 2004; 5: 21–26.
Innis SM . Metabolic programming of long-term outcomes due to fatty acid nutrition in early life. Matern Child Nutr 2011; 7: 112–123.
Kavanagh K, Jones KL, Sawyer J, Kelley K, Carr JJ, Wagner JD et al. Trans fat diet induces abdominal obesity and changes in insulin sensitivity in monkeys. Obesity 2007; 15: 1675–1684.
Koh-Banerjee P, Chu N-F, Spiegelman D, Rosner B, Colditz G, Willett W et al. Prospective study of the association of changes in dietary intake, physical activity, alcohol consumption, and smoking with 9-y gain in waist circumference among 16 587 US men. Am J Clin Nutr 2003; 78: 719–727.
Dahm CC, Gorst-Rasmussen A, Jakobsen MU, Schmidt EB, Tjønneland A, Sørensen TIA et al. Adipose tissue fatty acid patterns and changes in anthropometry: a cohort study. PLoS One 2011; 6: e22587.
Bild DE, Bluemke DA, Burke GL, Detrano R, Roux AVD, Folsom AR et al. Multi-Ethnic Study of Atherosclerosis: objectives and design. Am J Epidemiol 2002; 156: 871–881.
Nettleton JA, Rock CL, Wang Y, Jenny NS, Jacobs DR . Associations between dietary macronutrient intake and plasma lipids demonstrate criterion performance of the Multi-Ethnic Study of Atherosclerosis (MESA) food-frequency questionnaire. Br J Nutr 2009; 102: 1220–1227.
Mayer-Davis EJ, Vitolins MZ, Carmichael SL, Hemphill S, Tsaroucha G, Rushing J et al. Validity and reproducibility of a food frequency interview in a Multi-Cultural Epidemiologic Study. Ann Epidemiol 1999; 9: 314–324.
Block G, Woods M, Potosky A, Clifford C . Validation of a self-administered diet history questionnaire using multiple diet records. J Clin Epidemiol 1990; 43: 1327–1335.
Guenther PM, Reedy J, Krebs-Smith SM, Reeve BB . Evaluation of the Healthy Eating Index-2005. J Am Diet Assoc 2008; 108: 1854–1864.
Bertoni AG, Whitt-Glover MC, Chung H, Le KY, Barr RG, Mahesh M et al. The association between physical activity and subclinical atherosclerosis: the Multi-Ethnic Study of Atherosclerosis. Am J Epidemiol 2009; 169: 444–454.
Cao J, Schwichtenberg KA, Hanson NQ, Tsai MY . Incorporation and clearance of omega-3 fatty acids in erythrocyte membranes and plasma phospholipids. Clin Chem 2006; 52: 2265–2272.
PROC GLM Statistical Assumptions for Using PROC GLM :: SAS/STAT(R) 9.2 User’s Guide, Second Edition [Internet]. [cited 5 January 2017]. Available from http://support.sas.com/documentation/cdl/en/statug/63033/HTML/default/viewer.htm#statug_glm_sect026.htm.
Ainsworth BE, Haskell WL, Whitt MC, Irwin ML, Swartz AM, Strath SJ et al. Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exerc 2000; 32: S498–S516.
Kris-Etherton PM, Harris WS, Appel LJ, Committee for the N. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 2002; 106: 2747–2757.
Otto MC, de O, Wu JHY, Baylin A, Vaidya D, Rich SS, Tsai MY et al. Circulating and dietary omega-3 and omega-6 polyunsaturated fatty acids and incidence of CVD in the Multi-Ethnic Study of Atherosclerosis. J Am Heart Assoc 2013; 2: e000506.
Buckley JD, Howe PRC . Anti-obesity effects of long-chain omega-3 polyunsaturated fatty acids. Obes Rev 2009; 10: 648–659.
Massiera F, Saint-Marc P, Seydoux J, Murata T, Kobayashi T, Narumiya S et al. Arachidonic acid and prostacyclin signaling promote adipose tissue development a human health concern? J Lipid Res 2003; 44: 271–279.
Jensen CL, Prager TC, Fraley JK, Chen H, Anderson RE, Heird WC . Effect of dietary linoleic/alpha-linolenic acid ratio on growth and visual function of term infants. J Pediatr 1997; 131: 200–209.
Bender N, Portmann M, Heg Z, Hofmann K, Zwahlen M, Egger M . Fish or n3-PUFA intake and body composition: a systematic review and meta-analysis. Obes Rev 2014; 15: 657–665.
Micallef M, Munro I, Phang M, Garg M . Plasma n−3 polyunsaturated fatty acids are negatively associated with obesity. Br J Nutr 2009; 102: 1370–1374.
Parra D, Ramel A, Bandarra N, Kiely M, Martínez JA, Thorsdottir I . A diet rich in long chain omega-3 fatty acids modulates satiety in overweight and obese volunteers during weight loss. Appetite 2008; 51: 676–680.
Kunesová M, Braunerová R, Hlavatý P, Tvrzická E et al. The influence of n−3 polyunsaturated fatty acids and very low calorie diet during a short-term weight reducing regimen on weight loss and serum fatty acid composition in severely obese women. Physiol Res 2006; 55: 63–72.
Tai CC, Ding ST . N-3 polyunsaturated fatty acids regulate lipid metabolism through several inflammation mediators: mechanisms and implications for obesity prevention. J Nutr Biochem 2010; 21: 357–363.
Alvheim AR, Malde MK, Osei-Hyiaman D, Hong YH, Pawlosky RJ, Madsen L et al. Dietary linoleic acid elevates endogenous 2-AG and anandamide and induces obesity. Obesity 2012; 20: 1984–1994.
de Vries PS, Gielen M, Rizopoulos D, Rump P, Godschalk R, Hornstra G et al. Association between polyunsaturated fatty acid concentrations in maternal plasma phospholipids during pregnancy and offspring adiposity at age 7: the MEFAB cohort. Prostaglandins Leukot Essent Fat Acids 2014; 91: 81–85.
Muhlhausler BS, Ailhaud GP . Omega-6 polyunsaturated fatty acids and the early origins of obesity. Curr Opin Endocrinol Diabetes Obes 2013; 20: 56–61.
Food and Drug Administration, HHS. Food labeling: trans fatty acids in nutrition labeling, nutrient content claims, and health claims. Final rule. Fed Regist 2003; 68: 41433–41506.
Restricting trans Fatty Acids in the Food Supply [Internet]. [cited 30 June 2016]. Available from. http://www.apha.org/policies-and-advocacy/public-health-policy-statements/policy-database/2014/07/23/09/40/restricting-trans-fatty-acids-in-the-food-supply.
Honors MA, Harnack LJ, Zhou X, Steffen LM . Trends in fatty acid intake of adults in the Minneapolis-St Paul, MN Metropolitan area, 1980–1982 through 2007–2009. J Am Heart Assoc 2014; 3: e001023.
Baylin A, Campos H . The use of fatty acid biomarkers to reflect dietary intake. Curr Opin Lipidol 2006; 17: 22–27.
Hodge AM, Simpson JA, Gibson RA, Sinclair AJ, Makrides M, O’Dea K et al. Plasma phospholipid fatty acid composition as a biomarker of habitual dietary fat intake in an ethnically diverse cohort. Nutr Metab Cardiovasc Dis 2007; 17: 415–426.
Acknowledgements
This research was supported by P60MD002249 from the National Institute on Minority Health and Health Disparities (to TAH); by contracts HHSN268201500003I, N01-HC-95159, N01-HC-95160, N01-HC-95161, N01-HC-95162, N01-HC-95163, N01-HC-95164, N01-HC-95165, N01-HC-95166, N01-HC-95167, N01-HC-95168 and N01-HC-95169 from the National Heart, Lung, and Blood Institute, and by grants UL1-TR-000040, UL1-TR-001079 and UL1-TR-001420 from NCATS. We thank the other investigators, the staff and the participants of the MESA study for their valuable contributions. A full list of participating MESA investigators and institutions can be found at http://www.mesa-nhlbi.org
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies this paper on International Journal of Obesity website
Supplementary information
Rights and permissions
About this article
Cite this article
Hastert, T., de Oliveira Otto, M., Lê-Scherban, F. et al. Association of plasma phospholipid polyunsaturated and trans fatty acids with body mass index: results from the Multi-Ethnic Study of Atherosclerosis. Int J Obes 42, 433–440 (2018). https://doi.org/10.1038/ijo.2017.282
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ijo.2017.282
This article is cited by
-
Higher erythrocyte n-3 polyunsaturated fatty acid were associated with a better profile of DXA-derived body fat and fat distribution in adults
International Journal of Obesity (2020)